| (Values in U.S. Thousands) | Sep, 2022 | Jun, 2022 | Mar, 2022 | Dec, 2021 | Sep, 2021 |
| Sales | 265,920 | 277,150 | 269,850 | 261,180 | 248,140 |
| Sales Growth | -4.05% | +2.71% | +3.32% | +5.26% | -1.76% |
| Net Income | 106,130 | 54,550 | 60,330 | 45,750 | 56,950 |
| Net Income Growth | +94.56% | -9.58% | +31.87% | -19.67% | +314.66% |
Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Abiomed Inc. is engaged in developing, manufacturing and marketing of medical products, designed to assist or replace the pumping function of the failing heart.
Fiscal Year End Date: 03/31